Cyclophosphamide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cyclophosphamide and local guidelines before prescribing.

Alkylating cytotoxic and immunosuppressant

Mechanism

Alkylating agent crosslinking DNA (prodrug activated in liver).

Uses

Lymphoma, leukaemia, breast cancer, lupus nephritis, vasculitis, severe connective tissue disease.

Dosing

Side effects

Nausea, marrow suppression, haemorrhagic cystitis, infertility, infection, secondary malignancy.

Interactions

Allopurinol increases marrow toxicity; CYP inducers and inhibitors alter activation.

Contraindications and cautions

Active infection, severe marrow suppression, haemorrhagic cystitis

Monitoring

FBC, U&E, urinalysis for haematuria

Pregnancy and breastfeeding

Contraindicated (teratogenic); avoid breastfeeding

Renal and hepatic impairment

Reduce dose in renal and hepatic impairment

Overdose and reversal

Supportive; mesna for bladder protection

Special advice

Hydrate well and use mesna in high-dose regimens; discuss fertility preservation; check FBC before each dose.

More from the textbook: uses, cautions and other points
Where it is discussed in the book